1. Home
  2. NAII vs NKGN Comparison

NAII vs NKGN Comparison

Compare NAII & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAII
  • NKGN
  • Stock Information
  • Founded
  • NAII 1980
  • NKGN 2017
  • Country
  • NAII United States
  • NKGN United States
  • Employees
  • NAII N/A
  • NKGN N/A
  • Industry
  • NAII Medicinal Chemicals and Botanical Products
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NAII Health Care
  • NKGN Health Care
  • Exchange
  • NAII Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • NAII 26.2M
  • NKGN 22.6M
  • IPO Year
  • NAII 1987
  • NKGN N/A
  • Fundamental
  • Price
  • NAII $4.21
  • NKGN $0.44
  • Analyst Decision
  • NAII
  • NKGN
  • Analyst Count
  • NAII 0
  • NKGN 0
  • Target Price
  • NAII N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • NAII 6.5K
  • NKGN 438.4K
  • Earning Date
  • NAII 02-11-2025
  • NKGN 01-28-2025
  • Dividend Yield
  • NAII N/A
  • NKGN N/A
  • EPS Growth
  • NAII N/A
  • NKGN N/A
  • EPS
  • NAII N/A
  • NKGN N/A
  • Revenue
  • NAII $112,977,000.00
  • NKGN N/A
  • Revenue This Year
  • NAII N/A
  • NKGN N/A
  • Revenue Next Year
  • NAII N/A
  • NKGN N/A
  • P/E Ratio
  • NAII N/A
  • NKGN N/A
  • Revenue Growth
  • NAII N/A
  • NKGN N/A
  • 52 Week Low
  • NAII $4.02
  • NKGN $0.20
  • 52 Week High
  • NAII $7.26
  • NKGN $4.06
  • Technical
  • Relative Strength Index (RSI)
  • NAII 45.33
  • NKGN 40.80
  • Support Level
  • NAII $4.15
  • NKGN $0.45
  • Resistance Level
  • NAII $4.25
  • NKGN $0.53
  • Average True Range (ATR)
  • NAII 0.07
  • NKGN 0.10
  • MACD
  • NAII 0.00
  • NKGN -0.03
  • Stochastic Oscillator
  • NAII 24.00
  • NKGN 8.61

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: